Imagion set to improve cancer detection through molecular MRI
Imagion Biosystems to use funds from $3m capital raise to advance MagSense platform technology Through MagSense, Imagion aims to revolutionise cancer diagnosis by introducing molecular imaging to MRI The company is pursuing initial indication in HER2+ …